A total ion chromatogram obtained by GC-MS/MS for essential oil composition in leaves of C. grandis ‘Tomentosa’ was shown in Fig. 1. In total, 61 essential oil chemical components were identified and listed in Table 1. The families of detected essential oils in leaves mainly included terpenes (48.41%) and the oxygen containing derivatives of the terpenes-alcohols (34.73), which were consistent with the previous reports, but the contents was higher than those extracted in the same method from the Citri Grandis Exocarpium (fruit) [12]. The major compound was β-caryophyllene (15.75%), followed by (3R,6E)-nerolidol (12.66%), bicyclogermacrene (10.74%), β-citronellol (5.21%), 1-Methyl-4-(1-methylethylidene)-2-(1-methylvinyl)-1-vinylcyclohexane (4.92%), geraniol (4.12%) and phytol (4.03%).
Network construction of active component-target-disease
Diseases achieved from Therapeutic Target Database (TTD) were shown in Table 3. These diseases could be classified as tumors, immune diseases, neurodegenerative diseases and respiratory diseases. Tumors mainly included oral cancer, solid tumor/cancer, Paget's disease, melanoma, non-small-cell lung cancer, neoplasm and colorectal cancer. Immune diseases included rheumatoid arthritis, inflammation, autoimmune diabetes, immune system disease and arthritis. Neurodegenerative diseases involved Alzheimer disease and cognitive impairment. Respiratory diseases mainly included asthma and chronic obstructive pulmonary disease.
Table 3
Diseases obtained from TTD based on the targets via PPI network analysis
Target
|
Disease
|
Target
|
Disease
|
TNF
|
Rheumatoid arthritis; Intermittent claudication
|
DUSP1
|
Non-small-cell lung cancer
|
TP53
|
Oral cancer;
Solid tumour/cancer
|
MAP2K1
|
Solid tumour/cancer
|
STAT3
|
Inflammation;
Immune System disease
|
PTGES
|
Alzheimer disease; Neoplasm
|
PTGS2
|
Pain; Arthritis
|
HMOX1
|
Neonatal hyperbilirubinemia
|
MAPKAPK2
|
Inflammation;
Autoimmune diabetes
|
PLA2G4A
|
Asthma
|
FDPS
|
Hypercalcaemia;
Paget's disease
|
CDC25B
|
Solid tumour/cancer
|
IL1B
|
Immune System disease; Hypercalcaemia
|
CASP3
|
Solid tumour/cancer
|
CXCL8
|
Melanoma; Pain
|
MKNK1
|
Solid tumour/cancer; Colorectal cancer
|
ALOX5
|
Asthma;
Lymphatic filariasis
|
CHRM1
|
Cognitive impairment; Chronic obstructive pulmonary disease
|
Active component-target-tumor network, active component-target-immune disease network, active component-target-neurodegenerative disease network and active component-target-respiratory disease network were established, respectively (Fig. 6). As shown in Fig. 6A, 9 essential oil compositions could act on CASP3, MAP2K1 and CDC25B, respectively and be associated with solid tumor/cancer. These 9 essential oil compositions were farnesol, geranyllinalool, α-Cadinol, T-Muurolol, torreyol, globulol, phytol, methyl palmitate and oleamide. Besides, butyl isodecyl phthalate and methyllinolenate could be linked to neoplasm by acting on PTGES. Tetradecanal, methyl palmitate and oleamide could be linked to Paget's disease by acting on FDPS. Linalool and β-elemene could act on TP53 and be associated with oral cancer and solid tumor/cancer. As shown in Fig. 6B, 34 essential oil compositions could act on PTGS2 and be linked to arthritis. The essential oil compositions included phytol, isophytol, farnesol, cadalin, germacrene B, caryophyllene oxide, (-)-γ-cadinene, bicyclogermacrene, (-)-germacrene D, (1R,4aR,8aS)-7-methyl-4-methylidene-1-propan-2-yl-2,3,4a,5,6,8a-hexahydro-1H-naphthalene, (Z)-caryophyllene, γ-elemene, β-caryophyllene, isocaryophyllene, geranyl acetate, α-copaene, α-cubebene, geraniol, neral, isogeraniol, nerol, β-citronellol, terpinolene, D-limonene, β-elemene, linalool, methyl palmitate, citral, bis(2-ethylhexyl) adipate, oleamide, methyllinolenate, farnesal, (3R,6E)-nerolidol and neryl acetate. There was also an interaction among the essential oil compositions citral and methyl palmitate, the target TNF, and the disease rheumatoid arthritis. Figure 6C revealed that butyl isodecyl phthalate and methyllinolenate could be connected to Alzheimer disease by acting on PTGES. Besides, CHRM1 was forecasted as the major target for the treatment of cognitive impairment, of which 32 essential oil compositions (isospathulenol, spathulenol, β-lonone, α-cadinol, torreyol, T-muurolol, globulol, (-)-cis-Carveol, (R)-(+)-citronellal, geranyllinalool, phytol, isophytol, cadalin, caryophyllene oxide, (-)-γ-cadinene, (1R,4aR,8aS)-7-methyl-4-methylidene-1-propan-2-yl-2,3,4a,5,6,8a-hexahydro-1H-naphthalene, (Z)-caryophyllene, β-caryophyllene, isocaryophyllene, α-copaene, α-cubebene, neral, terpinolene, D-limonene, β-elemene, citral, butyl isodecyl phthalate, farnesal, viridiflorol, (3R,6E)-nerolidol, geranylacetone, and neryl acetate) were connected with them. As shown in Fig. 6D, 6 essential oil compositions could act on PLA2G4A and ALOX5, respectively and be associated with asthma. These 6 essential oil compositions were methyl palmitate, oleamide, farnesal, methyllinolenate, butyl isodecyl phthalate and neryl acetate. 32 essential oil compositions (isospathulenol, spathulenol, β-lonone, α-cadinol, torreyol, T-muurolol, globulol, (-)-cis-carveol, geranyllinalool, (R)-(+)-citronellal, phytol, isophytol, cadalin, caryophyllene oxide, (-)-γ-cadinene, (1R,4aR,8aS)-7-methyl-4-methylidene-1-propan-2-yl-2,3,4a,5,6,8a-hexahydro-1H-naphthalene, (Z)-Caryophyllene, β-Caryophyllene, isocaryophyllene, α-copaene, α-cubebene, neral, terpinolene, D-limonene, β-elemene, citral, butyl isodecyl phthalate, farnesal, viridiflorol, (3R,6E)-nerolidol, geranylacetone and neryl acetate) were predicted as the major ingredients in leaves of C. grandis ‘Tomentosa’ for the treatment of chronic obstructive pulmonary disease, and CHRM1 was regarded as the key target.